Exact Mass: 555.2247
Exact Mass Matches: 555.2247
Found 171 metabolites which its exact mass value is equals to given mass value 555.2247
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Rociletinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
2-amino-5-[(5-beta-D-glucopyranosyl-4-hydroxy-cyclopent-2-enylamino)-methyl]-7-beta-D-ribofuranosyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one
Cys Phe Met Arg
Cys Phe Arg Met
Cys Phe Thr Trp
Cys Phe Trp Thr
Cys Met Phe Arg
Cys Met Arg Phe
Cys Arg Phe Met
Cys Arg Met Phe
Cys Thr Phe Trp
Cys Thr Trp Phe
Cys Trp Phe Thr
Cys Trp Thr Phe
Asp Phe Phe Gln
Asp Phe Gln Phe
Asp Gln Phe Phe
Glu Phe Phe Asn
Glu Phe Asn Phe
Glu Asn Phe Phe
Phe Cys Met Arg
Phe Cys Arg Met
Phe Cys Thr Trp
Phe Cys Trp Thr
Phe Asp Phe Gln
Phe Asp Gln Phe
Phe Glu Phe Asn
Phe Glu Asn Phe
Phe Phe Asp Gln
Phe Phe Glu Asn
Phe Phe Asn Glu
Phe Phe Gln Asp
Phe Met Cys Arg
Phe Met Met Gln
Phe Met Gln Met
Phe Met Arg Cys
Phe Asn Glu Phe
Phe Asn Phe Glu
Phe Gln Asp Phe
Phe Gln Phe Asp
Phe Gln Met Met
Phe Arg Cys Met
Phe Arg Met Cys
Phe Thr Cys Trp
Phe Thr Trp Cys
Phe Trp Cys Thr
Phe Trp Thr Cys
Gly Met Trp Tyr
Gly Met Tyr Trp
Gly Trp Met Tyr
Gly Trp Tyr Met
Gly Tyr Met Trp
Gly Tyr Trp Met
Met Cys Phe Arg
Met Cys Arg Phe
Met Phe Cys Arg
Met Phe Met Gln
Met Phe Gln Met
Met Phe Arg Cys
Met Gly Trp Tyr
Met Gly Tyr Trp
Met Met Phe Gln
Met Met Gln Phe
Met Gln Phe Met
Met Gln Met Phe
Met Arg Cys Phe
Met Arg Phe Cys
Met Trp Gly Tyr
Met Trp Tyr Gly
Met Tyr Gly Trp
Met Tyr Trp Gly
Asn Glu Phe Phe
Asn Phe Glu Phe
Asn Phe Phe Glu
Asn Pro Tyr Tyr
Asn Tyr Pro Tyr
Asn Tyr Tyr Pro
Pro Asn Tyr Tyr
Pro Tyr Asn Tyr
Pro Tyr Tyr Asn
Gln Asp Phe Phe
Gln Phe Asp Phe
Gln Phe Phe Asp
Gln Phe Met Met
Gln Met Phe Met
Gln Met Met Phe
Arg Cys Phe Met
Arg Cys Met Phe
Arg Phe Cys Met
Arg Phe Met Cys
Arg Met Cys Phe
Arg Met Phe Cys
Ser Thr Trp Tyr
Ser Thr Tyr Trp
Ser Trp Thr Tyr
Ser Trp Tyr Thr
Ser Tyr Thr Trp
Ser Tyr Trp Thr
Thr Cys Phe Trp
Thr Cys Trp Phe
Thr Phe Cys Trp
Thr Phe Trp Cys
Thr Ser Trp Tyr
Thr Ser Tyr Trp
Thr Trp Cys Phe
Thr Trp Phe Cys
Thr Trp Ser Tyr
Thr Trp Tyr Ser
Thr Tyr Ser Trp
Thr Tyr Trp Ser
Trp Cys Phe Thr
Trp Cys Thr Phe
Trp Phe Cys Thr
Trp Phe Thr Cys
Trp Gly Met Tyr
Trp Gly Tyr Met
Trp Met Gly Tyr
Trp Met Tyr Gly
Trp Ser Thr Tyr
Trp Ser Tyr Thr
Trp Thr Cys Phe
Trp Thr Phe Cys
Trp Thr Ser Tyr
Trp Thr Tyr Ser
Trp Tyr Gly Met
Trp Tyr Met Gly
Trp Tyr Ser Thr
Trp Tyr Thr Ser
Tyr Gly Met Trp
Tyr Gly Trp Met
Tyr Met Gly Trp
Tyr Met Trp Gly
Tyr Asn Pro Tyr
Tyr Asn Tyr Pro
Tyr Pro Asn Tyr
Tyr Pro Tyr Asn
Tyr Ser Thr Trp
Tyr Ser Trp Thr
Tyr Thr Ser Trp
Tyr Thr Trp Ser
Tyr Trp Gly Met
Tyr Trp Met Gly
Tyr Trp Ser Thr
Tyr Trp Thr Ser
Tyr Tyr Asn Pro
Tyr Tyr Pro Asn
Rucaparib Camsylate
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C62554 - Poly (ADP-Ribose) Polymerase Inhibitor C471 - Enzyme Inhibitor
N-(Ethylsulfonyl)tryptophyl-N~1~-{4-[amino(imino)methyl]benzyl}glutamamide
Rociletinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
(7,7-Dimethyl-2-oxo-1-bicyclo[2.2.1]heptanyl)methanesulfonic acid;6-fluoro-2-[4-(methylaminomethyl)phenyl]-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one
(2R)-3-hydroxy-2-{[6-O-(6-O-octanoyl-alpha-D-glucopyranosyl)-alpha-D-glucopyranosyl]oxy}propanoate
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[[(1S,2R,4R,7Z,11S)-4,8-dimethyl-13-oxo-3,14-dioxatricyclo[9.3.0.02,4]tetradec-7-en-12-yl]methylsulfanyl]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
2-O-[6-O-Octanoyl-alpha-D-glucopyranosyl-(1->6)-alpha-D-glucopyranosyl]-D-glycerate
3-(4-fluorophenyl)-1-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
(3R)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N-(pyridin-4-ylmethyl)-4-(3-pyridin-4-ylphenyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N-(pyridin-4-ylmethyl)-4-(3-pyridin-4-ylphenyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
3-vinylbacteriochlorophyllide d(1-)
A cyclic tetrapyrrole anion that is the conjugate base of 3-vinylbacteriochlorophyllide d, obtained by deprotonation of the carboxy group; major species at pH 7.3.